NCT03253952

Brief Summary

The study is designed to investigate whether autonomic shifts (dysautonomia, sympatho-vagal instability) that develop after SCI have value in predicting SCI-associated infections (SCI-AI). SCI-AI impair outcomes by (1) reducing the intrinsic neurological recovery potential and (2) increasing mortality. Heart Rate Variability (HRV) data will be tracked in both the time and frequency domains to discriminate between the relative contribution of sympathetic and parasympathetic innervation to changes in HRV. The ability to predict infections will enable novel treatments thereby reducing infection-associated mortality and improving neurological and functional outcomes.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for all trials

Timeline
20mo left

Started Sep 2017

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress84%
Sep 2017Dec 2027

First Submitted

Initial submission to the registry

August 9, 2017

Completed
9 days until next milestone

First Posted

Study publicly available on registry

August 18, 2017

Completed
1 month until next milestone

Study Start

First participant enrolled

September 29, 2017

Completed
7.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2025

Completed
2.5 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2027

Expected
Last Updated

August 11, 2025

Status Verified

August 1, 2025

Enrollment Period

7.8 years

First QC Date

August 9, 2017

Last Update Submit

August 6, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Sympatho-vagal instability as an identifier for patients at risk for Spinal Cord Injury Associated Infections

    Determining whether discrete signs of loss of autonomic control (dysautonomia), not meeting defined criteria of full-autonomic dysreflexia, also renders patients "at risk" for developing infections.

    At all study time-points for a period of 24hours.

Study Arms (2)

Traumatic Spinal Cord Injury

Observational study - monitoring immune response and heart rate variability

Traumatic Spine Fracture, Control Group

Observational study - monitoring immune response and heart rate variability acting as a control group.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

SCI patients (n=50 subjects), Isolated Spinal fracture patients (n=10)

You may qualify if:

  • Patients with acute isolated spinal cord injury (AIS A-D) planned for surgical stabilization and decompression, lesion may include more than 1 segment
  • Patients with acute isolated spinal fracture, lesion may include more than 1 segment
  • Legal age of the patient
  • Documented informed consent of the patient

You may not qualify if:

  • Non-traumatic spinal cord injury
  • Concomitant traumatic brain injury (TBI) (definition: i) patient with severe TBI (Glasgow Coma Scale ≤ 8) and ii) patients with intracranial pressure monitoring sensors)
  • Neoplasia and/or antineoplastic therapy
  • Pregnancy, lactation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The Ohio State University Wexner Medical Center

Columbus, Ohio, 43210, United States

Location

MeSH Terms

Conditions

Spinal Cord InjuriesSpinal Fractures

Condition Hierarchy (Ancestors)

Spinal Cord DiseasesCentral Nervous System DiseasesNervous System DiseasesTrauma, Nervous SystemWounds and InjuriesSpinal InjuriesBack InjuriesFractures, Bone

Study Officials

  • Jan M Schwab, MD, PhD

    Ohio State University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Director of Spinal Cord Medicine

Study Record Dates

First Submitted

August 9, 2017

First Posted

August 18, 2017

Study Start

September 29, 2017

Primary Completion

June 30, 2025

Study Completion (Estimated)

December 31, 2027

Last Updated

August 11, 2025

Record last verified: 2025-08

Locations